Submitted by Anonymous (not verified) on 5 July 2024 - 13:23
Opinion/decision on a Paediatric investigation plan (PIP): Kyntheum, brodalumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Dermatology, PIP number: P/0212/2023
Source: